Search results

1. ASCO 2025 – Astra "looked at" patritumab but passed

   ASCO 2025 – Astra "looked at" patritumab but passed …

   
    

   Jacob Plieth
    
   - 06/02/2025 - 19:02

2. ASCO 2025 – Dizal goes after the BTK leaders

   ASCO 2025 – Dizal goes after the BTK leaders …

   
    

   Jacob Plieth
    
   - 06/05/2025 - 16:57

3. ASCO 2025 – BioNTech’s latest Claudin6 effort falls short

   ASCO 2025 – BioNTech’s latest Claudin6 effort falls … Note: *another 4 responses were unconfirmed. Source: ASCO 2025 & ESMO 2024.   Complicating the cross-trial …

   
    

   Madeleine Armstrong
    
   - 06/01/2025 - 21:08

4. ASCO 2025 – 3SBio reveals what Pfizer got for its $1.25bn

   ASCO 2025 – 3SBio reveals what Pfizer got for its $1.25bn …

   
    

   Jacob Plieth
    
   - 06/01/2025 - 21:06

5. ASCO 2025 – Exelixis’s son of Cabometyx improves

   ASCO 2025 – Exelixis’s son of Cabometyx improves …

   
    

   Madeleine Armstrong
    
   - 06/05/2025 - 11:12

6. ASCO 2025 – zilo-V adds a patient death to its tox tally

   ASCO 2025 – zilo-V adds a patient death to its tox tally …

   
    

   Jacob Plieth
    
   - 06/01/2025 - 21:07

7. ASCO 2025 – Astra's Matterhorn could break new ground

   ASCO 2025 – Astra's Matterhorn could break new ground …

   
    

   Jacob Plieth
    
   - 06/01/2025 - 21:22

8. ASCO 2025 – Astra seeks a new SERD paradigm

   ASCO 2025 – Astra seeks a new SERD paradigm …

   
    

   Madeleine Armstrong
    
   - 06/02/2025 - 14:04

9. ASCO 2025 – Enhertu mounts its first-line charge

   ASCO 2025 – Enhertu mounts its first-line charge … HR=0.56; p<0.00001 HR=0.62, p<0.0001 Source: ASCO 2025, Perjeta label.   Discussing the results at …

   
    

   Madeleine Armstrong
    
   - 06/04/2025 - 14:52

10. ASCO 2025 – Trodelvy heads for the front line

    ASCO 2025 – Trodelvy heads for the front line … 31% TEAE-related death 3% 3% Source: ASCO 2025.   Ascent-04 also saw an “early trend” …

    
     

    Madeleine Armstrong
     
    - 06/01/2025 - 21:07